BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is one of the best stocks to buy under $20. On October 1, BioCryst Pharmaceuticals announced the successful completion of the previously announced sale of its European ORLADEYO (berotralstat) business to Neopharmed Gentili. The transaction is valued at$250 million upfront, subject to customary purchase price adjustments, with the potential for BioCryst to receive up to $14 million in future milestones based on sales in Central and Eastern Europe. The divestitur ...